In multiple myeloma (MM), our previous transcriptomic analysis [38] revealed significantly higher ATOX1 expression in extramedullary multiple myeloma (EMM) patients compared to those with bone-marrow-confined MM (Figure 5A). This evidence concerns the gene ATOX1 and plasma cell myeloma.